+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy and cost-effectiveness of stereotactic vacuum-assisted core biopsy of nonpalpable breast lesions: analysis of 602 biopsies performed over 5 years



Efficacy and cost-effectiveness of stereotactic vacuum-assisted core biopsy of nonpalpable breast lesions: analysis of 602 biopsies performed over 5 years



La Radiologia Medica 116(3): 477-488



The authors sought to evaluate the diagnostic accuracy and cost-effectiveness of vacuum-assisted core biopsy (VACB) in comparison with diagnostic surgical excision for characterisation of nonpalpable breast lesions classified as Breast Imaging Reporting and Data System (BI-RADS) categories R3 and R4. From January 2004 to December 2008, we conducted 602 stereotactic, 11-gauge, VACB procedures on 243 nonpalpable breast lesions categorised as BI-RADS R3, 346 categorised as BI-RADS R4 and 13 categorised as BI-RADS R5. We calculated the diagnostic accuracy and cost savings of VACB by subtracting the cost of the stereotactic biopsy from that of the diagnostic surgical procedure. A total of 56% of the lesions were benign and required no further assessment. Lesions of uncertain malignant potential (B3) (23.6%) were debated at multidisciplinary meetings, and diagnostic surgical biopsy was recommended for 83.1% of them. All malignant lesions (B4 and B5) underwent surgical excision. VACB had a sensitivity of 94.9%, specificity of 98.3% and diagnostic accuracy of 97.7%. The cost savings per VACB procedure were 464.00 euro; by obviating 335 surgical biopsies, the overall cost savings was 155,440.00 euro over 5 years. VACB proved to have high diagnostic accuracy for characterising abnormalities at low to intermediate risk of malignancy and obviated surgical excision in about half of the cases, allowing for considerable cost savings.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052894754

Download citation: RISBibTeXText

PMID: 21225359

DOI: 10.1007/s11547-011-0625-x


Related references

Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy. British Journal of Cancer 90(2): 383-392, 26 January, 2004

Breast biopsy for mammographically detected nonpalpable lesions using a vacuum-assisted biopsy device (Mammotome) and upright-type stereotactic mammography unit without a digital imaging system: experience of 500 biopsies. Breast Cancer 21(2): 123-127, 2016

Breast biopsy for mammographically detected nonpalpable lesions using a vacuum-assisted biopsy device Mammotome and upright-type stereotactic mammography unit without a digital imaging system experience of 5 biopsies. 2014

Stereotactic breast biopsy of noncalcified lesions: a cost-minimization analysis comparing 14-gauge multipass automated core biopsy to 14- and 11-gauge vacuum-assisted biopsy. Clinical Imaging 29(1): 26-33, 2005

Stereotactic vacuum-assisted breast biopsy in 268 nonpalpable lesions. La Radiologia Medica 113(1): 65-75, 2008

Cost analysis of stereotactic vacuum assisted core biopsy vs stereotactic large core excisional biopsy vs needle localization biopsy by pathologic outcome. Breast Cancer Research & Treatment 64(1): 57, 2000

On the diagnostic accuracy of stereotactic vacuum-assisted biopsy of nonpalpable breast abnormalities. Results in a consecutive series of 769 procedures performed at the Trento Department of Breast Diagnosis. Tumori 98(1): 113-118, 2012

Breast biopsies: stereotactic vacuum-assisted core biopsy and stereotactic surgical breast biopsy. Gynecologie, Obstetrique and Fertilite 31(3): 256-264, 2003

Cost-Utility Analysis of two Ultrasound-Guided Breast Biopsies: Vacuum-Assisted Biopsy Versus Conventional Core Needle Biopsy. Value in Health 21: S171-S172, 2018

Intraoperative ultrasonographically guided excisional biopsy or vacuum-assisted core needle biopsy for nonpalpable breast lesions. Annals of Surgery 238(5): 738-742, 2003

Cost-effectiveness of percutaneous core needle breast biopsy (CNBB) versus open surgical biopsy (OSB) of nonpalpable breast lesions: metaanalysis and cost evaluation for German-speaking countries. Rofo 180(2): 134-142, 2007

Stereotactic breast biopsy of noncalcified lesionsA cost-minimization analysis comparing 14-gauge multipass automated core biopsy to 14- and 11-gauge vacuum-assisted biopsy. Clinical Imaging 29(1): 26-33, 2005

Cost and efficacy trade-offs of surgical biopsy vs stereotactic breast biopsy in women with nonpalpable mammographically detected lesions. Jgim 10(4 Suppl ): 52, 1995

Mucocele-like lesions of the breast: management after diagnosis on ultrasound guided core biopsy or stereotactic vacuum-assisted biopsy. Gynecologie, Obstetrique and Fertilite 38(7-8): 455-459, 2010

Stereotactic vacuum-assisted core biopsy results for non-palpable breast lesions. Asian Pacific Journal of Cancer Prevention 15(13): 5171-5174, 2015